Navigation Links
Phase I trial indicates ponatinib may thwart most resistant CML
Date:12/6/2010

ukemia and four were divided among other blood malignancies.

A total of 48 patients were evaluable at the time of reporting. Of these:

  • 30 of 32 patients (94 percent) in CML chronic phase had complete hematologic responses; 20 (63 percent) had major cytological responses, 12 complete and eight partial. Of these 20 cytogenetic responders, 18 remained on the treatment with no disease progression.

  • All 11 chronic phase CML patients who had the T315I mutation had complete hematologic response and nine had major cytogenetic responses, eight of which were complete.

  • For 16 CML patients in accelerated or blast phase or with Philadelphia-positive acute lymphocytic leukemia, five (31 percent) had a major hematological response and three (19 percent) had a major cytogenetic response.

  • Of nine CML patients in accelerated or blast phase or with Ph+ALL who also carried the T315I mutation, three (33 percent) had major hematologic response and two (22 percent) had major cytogenetic response.

Researchers also noted responses in patients with heavily resistant disease with no mutations and among patients with other mutations resistant to existing drugs.

The most common side effects were low platelet counts (24 percent of patients), headache (14 percent), nausea (14 percent), joint pain (13 percent), fatigue (13 percent), anemia (11 percent), increased lipase (11 percent), muscle spasms (11 percent), rash (11 percent), muscle pain (10 percent) and pancreatitis (10 percent). All dose-limiting toxicities were reversible.


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Assessing positive outcomes of phase III trials
2. Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
3. Nutrition rating enhancing front-of-package nutrition rating systems and symbols: Phase 1
4. New Phase II study shows first-line promise of lung cancer drug PF-299
5. Pazopanib shows promise in Phase II trial for relapsed/refractory urothelial cancer
6. Phase III study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors
7. Front-of-package symbols and systems: IOM phase 1 report
8. Vaccine extends glioblastoma patients survival in phase II trial
9. Operation Unified Response: 3 phases of disaster care in Haiti
10. Aeras and Crucell announce Phase II clinical trial start in Kenya
11. Sickle cell treatment developed at LA BioMed enters Phase 3 clinical trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Phase I trial indicates ponatinib may thwart most resistant CML
(Date:5/25/2015)... Burke Rehabilitation Hospital will welcome Samuel ... York City, to speak at Burke on Wednesday, June 3. ... Lobby Lecture series, will take place at 4:30 p.m. on ... grandson of Stanford White of McKim, Mead and White, the ... 100 years ago. , “We are thrilled to welcome Samuel ...
(Date:5/24/2015)... For people who are keen on the Enterokinase ... Research Report would be an useful report to refer ... present market scenario of this industry. The report also ... of this industry. The report summarizes key statistics of ... in this industry. The report is a valuable source ...
(Date:5/24/2015)... ProPin is a set of self-animating ... Utilize ProPin to pin point locations on a map, to ... , ProPin allows users to choose from 30 simplistic presets with ... on-screen controls, video editors can easily manipulate ProPin presets as a ... with absolute ease. , Using ProPin is easy, simply drag a ...
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers are ... City exactly five years to the day after the disastrous ... large fire tore through the Branches United Methodist Church and ... middle of the night as neighbors, staff and Branches' children ... though it is suspected that the fire began accidentally. Branches ...
(Date:5/23/2015)... On May 16, the team at ... a 5k mud obstacle run that raised funds for multiple ... worldwide, and the reason we participated was to support people ... of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised ... event was not only attended by eXtreme Bodyshaping staff, but ...
Breaking Medicine News(10 mins):Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2
... found the mechanism through which lipoic acid may help people ... vigour, free of degenerative disease, until very near death. ... process of ageing, improve blood flow, enhance immune function, and ... suggests that lipoic acid is actually a low-level stressor that ...
... Chemotherapy is a standard regimen in most cancer treatments. Since ... to replace it with something more comfortable for the ... the drug Zoladex switch off the ovary and stop the ... grow. ,An agonist achieves a normal action, often ...
... that the cox-2 inhibitor celecoxib, a common pain reliever used ... most common cause of brain damage in premature babies. ... part of the brain that in premature infants is very ... on an approximate 12,000 children a year, leaving many everlastingly ...
... the National Cancer Institute and Fred Hutchinson Cancer ... found in tomatoes , does not effectively prevent ... noted an association between beta-carotene, an antioxidant related ... prostate cancer. ,It is disappointing, since ...
... effort to strengthen and sustain its leadership in the companion ... of Wisconsin-Madison will establish a new Stem Cell and ... center, to be made today (May 17) at a public ... the cloned sheep Dolly, sets the stage for a critical ...
... making addition of folic acid to flour or bread mandatory in ... disabilities. ,After lengthy public consultations the Food Standards Agency ... recommendations next month after it decides whether folic acid should be ... accept the FSA's proposals, it will be the first time since ...
Cached Medicine News:Health News:Lipoic Acid may Help to Live Long, Free of Degenerative Disease 2Health News:A Fresh Alternative to Painful Chemotherapy Developed in UK 2Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 2Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 3Health News:Tomatoes are Not So Effective in Preventing Prostate Cancer 2Health News:UW Establishes Stem Cell and Regenerative Medicine Center 2Health News:UK too Will Insist on Folic Acid in Bread 2Health News:UK too Will Insist on Folic Acid in Bread 3
(Date:5/22/2015)... May 22, 2015 Richmond ... research unit with a worldwide reputation for excellence ... frequent publications in peer reviewed medical journals. Its ... and regulators in discussions about rules for transparency ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research ...
(Date:5/22/2015)... , May 22, 2015  China Nepstar Chain ... a leading retail drugstore chain in China ... stores, today announced the resignation of Mr. Fuxiang ... personal reasons, effective immediately. Ms. Rebecca Yingnan Zhang ... the Company,s board of directors, effective immediately. Meanwhile, Ms. ...
(Date:5/21/2015)... 21, 2015  When Ryan Rendino first ... of his neck, he figured it was ... weeks off from weight lifting. ... A series of doctor ... to Michel Kliot, MD , a ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC.  Founded in ... management and patient specimen tracking.  Based in Columbus, Georgia , Path-Tec positions itself as a complete outsourcing ... ... , ...
... WASHINGTON , March 22 Allan Coukell , director of the Pew Prescription Project, issued the following statement ... device companies to publicly report the gifts and payments they make to doctors.   , ... ... ...
Cached Medicine Technology:Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC 2Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC 3Pew Statement on the Physician Payments Sunshine Act 2
Solid 16 mm blades. Self-locking mechanism. Dull finish....
... speculum has wide solid blades ... clearance for the suction ring. ... lids and lashes to clear ... The blades are curved to ...
Angled 45 degrees. Open 13 mm blades. Screw-controlled locking mechanism. Dull finish....
Solid 21 mm blades. Screw-controlled locking mechanism. Dull finish....
Medicine Products: